2024 article

Comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban in dogs

Lynch, A. M., Ruterbories, L. K., Zhu, Y., Fialkiewicz, F., Papich, M. G., Brooks, M. B., & Goggs, R. (2024, October 17). JOURNAL OF VETERINARY INTERNAL MEDICINE.

By: A. Lynch n , L. Ruterbories n, Y. Zhu*, F. Fialkiewicz*, M. Papich n , M. Brooks *, R. Goggs *

author keywords: anticoagulant; anti-Xa; direct oral anticoagulant; DOAC; thrombin generation; thromboprophylaxis; thrombosis
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (OpenAlex)
Source: Web Of Science
Added: October 28, 2024

Comparative pharmacokinetics and pharmacodynamics (PK/PD) of apixaban and rivaroxaban have not been studied in dogs and the propensity of these drugs to cause hypercoagulability after discontinuation is unknown.